LAUREN HARDIMAN: Open Payments
NPI 1619381167 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,448 in 112 payments from 37 companies in 2025. Trend: 2023 $1,473 · 2024 $2,088 · 2025 $2,448
Food & beverage: $2,448
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $277 |
| E.R. Squibb & Sons, L.L.C. | 15 | $267 |
| AstraZeneca Pharmaceuticals LP | 11 | $244 |
| Genentech USA, Inc. | 3 | $169 |
| Celgene Corporation | 6 | $137 |
| PFIZER INC. | 7 | $121 |
| Merck Sharp & Dohme LLC | 5 | $110 |
| Daiichi Sankyo Inc. | 4 | $107 |
| ABBVIE INC. | 4 | $101 |
| Geron Corporation | 3 | $63 |
Products named: OPDIVO, Tecentriq, Enhertu, Fabhalta, KEYTRUDA, REBLOZYL, IMFINZI, KISQALI.
Industry payments across FL — which companies pay providers there.
